Citation 109853

SCHULTZE-MOSGAU,MH: DALE,IL: GANT,TW: CHIPMAN,JK: KERR,DJ: GESCHER,A:. (1998). REGULATION OF C-FOS TRANSCRIPTION BY CHEMOPREVENTIVE ISOFLAVONOIDS AND LIGNANS IN MDA-MB-468-BREAST CANCER CELLS.. 34(9)

Citation Details

Title	REGULATION OF C-FOS TRANSCRIPTION BY CHEMOPREVENTIVE ISOFLAVONOIDS AND LIGNANS IN MDA-MB-468-BREAST CANCER CELLS.
Authors	SCHULTZE-MOSGAU,MH: DALE,IL: GANT,TW: CHIPMAN,JK: KERR,DJ: GESCHER,A:
Year	1998
Volume	34
Issue	9

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
2	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
3	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	WEAK ACTIVITY
4	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	INACTIVE
5	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
6	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	INACTIVE
7	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	ACTIVE
8	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	INACTIVE
9	MALONDIALDEHYDE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	INACTIVE
10	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	WEAK ACTIVITY
11	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTEROLACTONE	INACTIVE
12	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTEROLACTONE	INACTIVE
13	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTEROLACTONE	INACTIVE
14	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTEROLACTONE	INACTIVE
15	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTEROLACTONE	WEAK ACTIVITY
16	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTERODIOL	INACTIVE
17	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTERODIOL	INACTIVE
18	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTERODIOL	INACTIVE
19	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTERODIOL	INACTIVE
20	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENTERODIOL	WEAK ACTIVITY
21	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	INACTIVE
22	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	INACTIVE
23	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	INACTIVE
24	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	INACTIVE
25	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE
26	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYL-LACTIC ACID METHYL ESTER,PARA-HYDROXY:	INACTIVE
27	ONCOGENE EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYL-LACTIC ACID METHYL ESTER,PARA-HYDROXY:	INACTIVE
28	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYL-LACTIC ACID METHYL ESTER,PARA-HYDROXY:	INACTIVE
29	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYL-LACTIC ACID METHYL ESTER,PARA-HYDROXY:	INACTIVE
30	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYL-LACTIC ACID METHYL ESTER,PARA-HYDROXY:	WEAK ACTIVITY

Citation 109853

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1